ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,348Medicare Part D Prescriptions Filled, Including Refills

Rank: 141 out of 1206

$758K Total Retail Price of All Prescriptions

Rank: 34 out of 1206

525 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 525 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 525 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,007 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 470 447 1 2
FUROSEMIDE 460 433 2 5
OMEPRAZOLE 447 414 3 3
SIMVASTATIN 435 388 4 1
LISINOPRIL 322 278 5 4
POTASSIUM CHLORIDE 283 247 6 12
DONEPEZIL HCL 235 229 7 29
ATENOLOL 233 227 8 14
CITALOPRAM HBR 205 196 9 16
HYDROCODONE-ACETAMINOPHEN 200 179 S3 10 7
POLYETHYLENE GLYCOL 3350 191 144 11 31
TRAMADOL HCL 182 137 12 17
AMLODIPINE BESYLATE 181 161 13 6
WARFARIN SODIUM 177 157 14 8
NAMENDA 161 155 15 36
METOPROLOL TARTRATE 157 145 16 9
TRAZODONE HCL 150 131 17 37
GABAPENTIN 147 130 18 18
ATORVASTATIN CALCIUM 144 128 19 13
SERTRALINE HCL 138 138 20 22
LANTUS 127 100 21 38
METFORMIN HCL 127 116 21 10
ZOLPIDEM TARTRATE 126 116 23 25
AMLODIPINE BESYLATE-BENAZEPRIL 107 91 24 76
ALLOPURINOL 107 107 24 24
METOPROLOL SUCCINATE 107 107 24 15
NOVOLOG 105 64 27 100
LANTUS SOLOSTAR 99 85 28 85
ALENDRONATE SODIUM 94 90 29 19
CIPROFLOXACIN HCL 89 79 30 61
ESCITALOPRAM OXALATE 87 62 31 86
FENTANYL 87 87 S2 31 51
MIRTAZAPINE 83 83 33 50
ACTOS 83 79 33 98
AZITHROMYCIN 80 71 35 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 62 36 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 68 37 27
BISOPROLOL-HYDROCHLOROTHIAZIDE 67 67 38 108
CYMBALTA 67 48 38 63
LOSARTAN POTASSIUM 61 58 40 20
TRIAMTERENE-HCTZ 61 61 40 33
PEN NEEDLE 58 26 42 121
PROAIR HFA 57 40 43 49
OXYBUTYNIN CHLORIDE ER 56 56 44 119
BENAZEPRIL HCL 55 55 45 39
BACLOFEN 55 30 45 137
HYDROCHLOROTHIAZIDE 53 53 47 11
PROPRANOLOL HCL 53 41 47 92
RISPERIDONE 52 52 49 74
EXELON 52 52 49 149
ALBUTEROL SULFATE 51 51 51 123
IPRATROPIUM-ALBUTEROL 51 51 51 139
TAMSULOSIN HCL 50 50 53 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.